243 related articles for article (PubMed ID: 8706015)
1. Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer.
Goto I; Yoneda S; Yamamoto M; Kawajiri K
Cancer Res; 1996 Aug; 56(16):3725-30. PubMed ID: 8706015
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.
Nakachi K; Imai K; Hayashi S; Kawajiri K
Cancer Res; 1993 Jul; 53(13):2994-9. PubMed ID: 8319207
[TBL] [Abstract][Full Text] [Related]
3. Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer.
Kawajiri K; Eguchi H; Nakachi K; Sekiya T; Yamamoto M
Cancer Res; 1996 Jan; 56(1):72-6. PubMed ID: 8548778
[TBL] [Abstract][Full Text] [Related]
4. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
[TBL] [Abstract][Full Text] [Related]
5. Influence of polymorphism at p53, CYP1A1 and GSTM1 loci on p53 mutation and association of p53 mutation with prognosis in lung cancer.
Wang YC; Chen CY; Wang HJ; Chen SK; Chang YY; Lin P
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):402-10. PubMed ID: 10418172
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
7. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
8. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
[TBL] [Abstract][Full Text] [Related]
9. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes.
Rojas M; Alexandrov K; Cascorbi I; Brockmöller J; Likhachev A; Pozharisski K; Bouvier G; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
Pharmacogenetics; 1998 Apr; 8(2):109-18. PubMed ID: 10022748
[TBL] [Abstract][Full Text] [Related]
10. The association between polymorphisms in glutathione S-transferase (GSTM1 and GSTT1) and lung cancer outcome.
Gonlugur U; Pinarbasi H; Gonlugur TE; Silig Y
Cancer Invest; 2006; 24(5):497-501. PubMed ID: 16939958
[TBL] [Abstract][Full Text] [Related]
11. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
12. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998
[TBL] [Abstract][Full Text] [Related]
14. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma.
Lu C; Spitz MR; Zhao H; Dong Q; Truong M; Chang JY; Blumenschein GR; Hong WK; Wu X
Cancer; 2006 Jan; 106(2):441-7. PubMed ID: 16342067
[TBL] [Abstract][Full Text] [Related]
15. Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer.
Masago K; Fujita S; Kim YH; Hatachi Y; Fukuhara A; Nagai H; Irisa K; Ichikawa M; Mio T; Mishima M
Cancer Sci; 2009 Oct; 100(10):1917-22. PubMed ID: 19594543
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
[TBL] [Abstract][Full Text] [Related]
17. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
To-Figueras J; Gene M; Gomez-Catalan J; Galan C; Firvida J; Fuentes M; Rodamilans M; Huguet E; Estape J; Corbella J
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):337-42. PubMed ID: 9162298
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients.
Zhou W; Heist RS; Liu G; Neuberg DS; Asomaning K; Su L; Wain JC; Lynch TJ; Giovannucci E; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2239-45. PubMed ID: 17119052
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
20. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
